Alodokter, the SoftBank Ventures-backed Indonesian digital health platform, has posted significant revenue growth even as its net losses widened for the year ended December 31, 2021, according to regulatory filings by its Singapore-registered parent company Ranelagh Pte Ltd.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
